Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Treat hirsutism in premenopausal women with oral contraceptives and consider additional treatments if needed.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

A 68-year-old woman developed male traits due to a tumor in her ovary, which was removed, returning her hormone levels to normal.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Progesterone may help trans women with breast development and health, but more research is needed.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

A rare ovarian tumor caused a postmenopausal woman to develop male-like features, which improved after surgery.

Losing weight, possibly through bariatric surgery, is key to improving PCOS and hyperandrogenism symptoms in obese patients.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

A young girl's hyperandrogenism was caused by an adrenocortical adenoma, diagnosed and treated through detailed evaluations.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

A low-glycemic diet improved hormone levels and well-being in overweight women with high androgen levels.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Vertical sleeve gastrectomy improved metabolism, behavior, and reproduction in obese rats with PCOS.

The treatment successfully lowered testosterone levels and reduced symptoms.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.